Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -16.51
- Piotroski Score 5.00
- Grade Buy
- Symbol (EVOK)
- Company Evoke Pharma, Inc.
- Price $4.35
- Changes Percentage (3.84%)
- Change $0.16
- Day Low $4.12
- Day High $4.38
- Year High $18.60
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.83
- Trailing P/E Ratio -0.31
- Forward P/E Ratio -0.31
- P/E Growth -0.31
- Net Income $-7,792,295
Income Statement
Quarterly
Annual
Latest News of EVOK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Judge considers revoking guilty plea of FTX executive Ryan Salame, accusing him of lying under oath
Salame, a former FTX executive, tried to withdraw his guilty plea but was grilled in court for lying about plea negotiations. His request to revoke the plea was denied. The judge may consider revoking...
By Business Insider | 1 day ago -
China's economic coercion evokes greater scrutiny and resentment, senior US officials say
Senior US officials criticized Beijing's coercive behavior globally, especially towards smaller nations like the Philippines. They discussed efforts to counter China's economic coercion and emphasized...
By Yahoo! Finance | 1 week ago -
GM revokes remote work status from more white-collar workers, orders them into office
General Motors is requiring about 100 white-collar workers to come into the office at least three days a week, revoking their "fully remote" status. The move aims to enhance collaboration among employ...
By Yahoo! Finance | 1 week ago
